A01N37/44

MICRONUTRIENT FORMULATIONS THAT CONTROL PLANT PATHOGENS
20220394981 · 2022-12-15 · ·

Disclosed are micronutrient chelate compositions and methods that provide nutrients to a plant to improve growth while controlling pathogens, such as Candidatus Liberibacter asiaticus the causal pathogen for citrus greening disease, by improving plant health through the enhancement of beneficial microbial populations resident in the plants phloem. The chelate compositions include a combination of a metal, such as iron, and a derivative of a chelating agent such as EDDHA or HBED. The chelate formulations can either be a dry formulation or liquid formulation that is dispersed in a selected amount of water and applied to the foliage of a plant and/or applied to the soil proximal to the plant rhizosphere.

METHOD AND COMPOSITION FOR REGULATING PLANT ARCHITECTURE
20220386546 · 2022-12-08 ·

A method for regulating plant architecture includes applying a composition containing γ-Aminobutyric acid (GABA), glutamic acid and choline chloride to a plant. The composition for regulating plant architecture is also provided.

METHOD AND COMPOSITION FOR REGULATING PLANT ARCHITECTURE
20220386546 · 2022-12-08 ·

A method for regulating plant architecture includes applying a composition containing γ-Aminobutyric acid (GABA), glutamic acid and choline chloride to a plant. The composition for regulating plant architecture is also provided.

METHOD AND COMPOSITION FOR REGULATING PLANT ARCHITECTURE
20220386546 · 2022-12-08 ·

A method for regulating plant architecture includes applying a composition containing γ-Aminobutyric acid (GABA), glutamic acid and choline chloride to a plant. The composition for regulating plant architecture is also provided.

BIOFILM TREATMENT AGENT AND BIOFILM TREATMENT METHOD
20220378043 · 2022-12-01 · ·

[Problem] A treatment agent having an excellent ability to remove biofilms and a biofilm treatment method in which the treatment agent is used are provided.

[Solution] A biofilm treatment agent characterized by containing at least A1 and/or A2 below. A1: An aromatic monohydric alcohol. A2: An anthranilic acid analog and a biosurfactant. Preferably, the biofilm treatment agent is characterized by containing at least an aromatic monohydric alcohol, an anthranilic acid analog, a biosurfactant, and a synthetic surfactant.

BIOFILM TREATMENT AGENT AND BIOFILM TREATMENT METHOD
20220378043 · 2022-12-01 · ·

[Problem] A treatment agent having an excellent ability to remove biofilms and a biofilm treatment method in which the treatment agent is used are provided.

[Solution] A biofilm treatment agent characterized by containing at least A1 and/or A2 below. A1: An aromatic monohydric alcohol. A2: An anthranilic acid analog and a biosurfactant. Preferably, the biofilm treatment agent is characterized by containing at least an aromatic monohydric alcohol, an anthranilic acid analog, a biosurfactant, and a synthetic surfactant.

BIOFILM TREATMENT AGENT AND BIOFILM TREATMENT METHOD
20220378043 · 2022-12-01 · ·

[Problem] A treatment agent having an excellent ability to remove biofilms and a biofilm treatment method in which the treatment agent is used are provided.

[Solution] A biofilm treatment agent characterized by containing at least A1 and/or A2 below. A1: An aromatic monohydric alcohol. A2: An anthranilic acid analog and a biosurfactant. Preferably, the biofilm treatment agent is characterized by containing at least an aromatic monohydric alcohol, an anthranilic acid analog, a biosurfactant, and a synthetic surfactant.

Synergic pharmaceutical composition of the active enantiomer (S)-ketorolac and Gabapentin for the treatment of neuropathic pain

This invention refers to a pharmaceutical composition that comprises the synergic combination of a NSAID, such as the active ingredient: S-ketorolac of tromethamine and a GABA derivative agent, such as the active ingredient: gabapentin, which are formulated with pharmaceutically acceptable excipients in a single dosing unit to be administered by oral, parenteral, topical, transdermal means or with the use of transdermal, oral or nasal inhalation devices, which is indicated for the treatment of neuropathic and/or nociceptive pain caused by different etiologies.

PLANT ACTIVATOR CONTAINING AMINO ACID OR SALT THEREOF, AND OLIGOSACCHARIDE, AND USE THEREOF

Physiological processes in plants are regulated and reinforced, and crop vitality, yield, quality and post-harvesting storage life are improved. A plant vitalizer containing an amino acid or its salt and an oligosaccharide is applied to plants.

PLANT ACTIVATOR CONTAINING AMINO ACID OR SALT THEREOF, AND OLIGOSACCHARIDE, AND USE THEREOF

Physiological processes in plants are regulated and reinforced, and crop vitality, yield, quality and post-harvesting storage life are improved. A plant vitalizer containing an amino acid or its salt and an oligosaccharide is applied to plants.